LTI-291
CAS No. 1919820-28-2
LTI-291( LTI-291 | LTI 291 | LTI291 )
Catalog No. M18176 CAS No. 1919820-28-2
LTI-291 is a glucocerebrosidase (Gcase) activator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 102 | In Stock |
|
| 2MG | 55 | In Stock |
|
| 5MG | 92 | In Stock |
|
| 10MG | 148 | In Stock |
|
| 25MG | 297 | In Stock |
|
| 50MG | 461 | In Stock |
|
| 100MG | 709 | In Stock |
|
| 200MG | 918 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLTI-291
-
NoteResearch use only, not for human use.
-
Brief DescriptionLTI-291 is a glucocerebrosidase (Gcase) activator.
-
DescriptionLTI-291 is a glucocerebrosidase (Gcase) activator for treatment of Parkinson's disease (PD).
-
In Vitro——
-
In Vivo——
-
SynonymsLTI-291 | LTI 291 | LTI291
-
PathwayOthers
-
TargetOther Targets
-
Recptorβ-glucosidase
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number1919820-28-2
-
Formula Weight358.49
-
Molecular FormulaC20H30N4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL 139.48 mM;
-
SMILESO=C(C1=C2N=C(C)C=C(C)N2N=C1)N[C@H]3CC[C@H](OCCCCC)CC3
-
Chemical Name5,7-Dimethyl-pyrazolo[1,5-a]pyrimidine-3-carboxylic acid (trans-4-pentyloxy-cyclohexyl)-amide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Renato T. Skerlj, et al. Methods of treatment and combination therapies using gcase activator heterobicyclic and related compounds. WO 2017192841 A1.
molnova catalog
related products
-
Cucurbit
Cucurbit[7]uril is an emerging candidate for pharmaceutical excipients.Cucurbit[7]uril enhances photosensitization of porphyrins in Neuroblastoma cells.
-
Calcium ionophore II
Calcium ionophore II (N,N,N′,N′-Tetracyclohexyl-3-oxapentanediamide) is a lipophilic ionophore utilized in preparing calcium ion-selective electrodes.
-
BAY-3827 B
BAY-3827 is a potent and selective AMPK inhibitor with potential antitumor activity, demonstrating antiproliferative effects in an androgen-dependent prostate cancer model and inhibiting the phosphorylation of acetyl CoA carboxylase 1 (ACC-1).
Cart
sales@molnova.com